NCT07407920 2026-02-12Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR TrialM.D. Anderson Cancer CenterPhase 2 Active not recruiting120 enrolled
NCT06876714 2026-02-04ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus TrastuzumabAlliance for Clinical Trials in OncologyPhase 3 Recruiting1,524 enrolled